Short peptide · memory and ageing · not approved
A small lab-made peptide promoted for memory and ageing, with only weak studies behind it. Whether you are curious, starting, or already using it, here is what helps.

Status as of November 17, 2026. For information only, not medical advice: read the medical disclaimer.
Where are you with Pinealon?
Good place to start. Here is what the studies really are, in plain words.
Pinealon is not FDA approved, and there are no trials of it on ClinicalTrials.gov. In Russia it is sold as a dietary supplement, not a medicine.
The human reports are small, and none had a proper comparison group. Most are Russian papers we could read only as short summaries, so their methods cannot be checked.
Almost all the research comes from one Russian network, and two of its authors are named inventors on the pinealon patent. We found no repeat of any finding outside Russian groups.
Despite the name, the one study of pineal gland cells found no effect. We found no study showing it raises melatonin.
Coming Pick your questions and print them as one page.
Here is what is known and what is not, and how to start with fewer unknowns.
No controlled trial has tested any amount of pinealon, so there is no reliable figure to point to. Any dose question belongs with your doctor.
The calculator turns the numbers on your own label into concentration and syringe units. It never suggests an amount. For clean technique, see how to reconstitute peptides.
If memory or sleep is what brought you here, it is worth having those checked by your doctor first, whatever you decide about pinealon.
You’re using it. Here’s what is known, what isn’t, and how to keep an honest record.
No controlled study has counted side effects. One small report found blood-cell changes that its authors read as slowed blood-cell making. Mention any new symptom to your doctor.
Your own notes cannot tell the peptide apart from hope or time. That is why trials use a comparison group.
No study has tested these together, and there are no data on mixing them in the same syringe.
No judgement. We won’t tell you where to buy or how much to take, but these steps lower the risk whatever you use:
Pinealon has no drug label, so there is no official list of warning signs. Here is what we can say honestly.
Emergency: call 911 (or your local emergency number). Possible overdose or wrong amount: Poison Help, 1-800-222-1222, free and open 24 hours. Report a bad reaction to the FDA through MedWatch.
Every number below says what kind of study it came from. Bracketed numbers point to the sources listed at the end.
No controlled study has followed people on pinealon over time, so there is no trial time course. The reports we could check ran for 10 days to 2 weeks and gave end results only.
Uncontrolled means no comparison. In these reports, no group got a dummy pill to compare against, with numbers given. Without a comparison group, a study cannot tell the peptide apart from other things, such as hope or the passing of time.
A conflict of interest, in plain words. The people who invented pinealon also wrote much of the research on it. Their 2020 review says they have no conflict of interest[4]. Yet two of its authors are named inventors on the patent[2]. This does not prove the results wrong. It means no one without a stake in them has checked them.
Short summaries only. Most human reports are Russian-language papers. We could read only their abstracts, so we cannot check their methods. Some numbers do not add up. One report says "32 people", but its listed men and women add to 30[5].
No label. In the US, pinealon has no approved label, so there is no official guide to storage or daily use. In Russia it is listed as a supplement, and the listing does not state how much peptide is in it[6].
No controlled study has counted side effects, so no one knows how often they happen. The patent reports "no negative effect" in 25 people, but it was written by the patent owner[2]. One small report found blood-cell changes that its authors read as slowed blood-cell making[5].
We do not show a tips list or a list of warning signs here. Pinealon has no drug label, and we do not make one up. If you feel unwell after any product, talk to a doctor or pharmacist and bring the product label.
Your own notes cannot tell the peptide apart from hope or time. That is why trials use a comparison group.
Any dose question belongs here. No controlled trial has tested a dose, so there is no reliable figure to point to.
What it is: a synthetic tripeptide, Glu-Asp-Arg (EDR), from the Khavinson group in St Petersburg[2]. Evidence: cell and animal studies, plus small uncontrolled Russian reports, mostly read as abstracts only. Status: not FDA approved; no trials on ClinicalTrials.gov[7]; not named by WADA but probably covered by its S0 catch-all; sold in Russia as a dietary supplement[6].
Pinealon reaches the small-human-study rung only through uncontrolled, low-quality Russian reports. No randomised trial exists.
Structure. Pinealon is the tripeptide Glu-Asp-Arg, formula C15H26N6O8, molecular weight 418.40 g/mol[8]. It is a peptide in the plain sense: a short chain of amino acids.
Who made it. The US patent names Khavinson, Grigoriev, Malinin and Ryzhak as inventors and describes making pinealon by chemical synthesis in solution, not by extraction (Example 1)[2]. The patent passed from SIA Peptides to Garmonia in 2014 and to Peptidpro in 2019. Google Patents lists it as expired for unpaid fees from October 2025. The group's 2020 review says pinealon was isolated from Cortexin, a polypeptide neuroprotective drug[4]; the patent does not mention this.
Sold in Russia as a supplement. The Russian drug register RLS lists Pinealon as a dietary supplement (BAA), not a medicine, in 0.2 g capsules and 0.16 g and 0.3 g tablets, without stating the peptide content[6].
The name suggests it does, but the evidence does not show it. In the only study of pineal gland cells, pinealon (EDR) did not change the markers measured, Ki-67 and AIF, while epitalon (AEDG) did (rat cell culture)[3]. We found no study showing that pinealon raises melatonin.
Cell and lab studies. These suggest how pinealon might act. They do not show an effect in people.
| Finding | Source | Study type |
|---|---|---|
| Less build-up of reactive oxygen species, fewer dying cells, delayed ERK1/2 activation in rat nerve and other cells | [9] | Cell |
| Entered the nucleus of HeLa cells and bound DNA in a test tube | [10] | Cell |
| Bound histone proteins in a test tube | [11] | Cell |
| Can partly enter the DNA major groove (modelling; the one paper outside the Khavinson group) | [12] | Cell |
| More serotonin expression in ageing brain-cell cultures | [13] | Cell |
| More dendrite growth in neurons grown from elderly donors' skin cells | [14] | Cell |
Animal studies. All are in rats or mice, and most come from the same research network. Several are Russian-language papers where only the abstract was available.
| Model | Amount and route | Finding | Source | Study type |
|---|---|---|---|---|
| Pregnant rats, high homocysteine | 10 µg/kg/day by injection into the abdomen, 5 days | Offspring learned better; less oxidative damage in brain cells | [15] | Animal |
| Rats, low-oxygen exposure | Not in abstract | Strongest anti-hypoxia effect of 4 short peptides | [16] | Animal |
| Old rats, blocked carotid artery | Not in abstract | Better survival; mixed behaviour effects | [17] | Animal |
| Rats, maze learning after low oxygen | Not in abstract | Pinealon improved learning more than Cortexin | [18] | Animal |
| Old rats, low oxygen and cold | Not in abstract | Cortexin had the larger effect on free radicals and caspase-3 | [19] | Animal |
| Rats, brain compression injury | 10 µg/kg into muscle at 1, 12, 48 and 96 h | About twice as many treated rats could learn at 96 h | US 8,524,674[2], Example 4 | Animal (patent, not peer reviewed) |
Human reports. None of these is a registered or blinded randomised trial. Most are Russian-language papers we could read only as abstracts, so their methods are unverified.
| Report | Design | People | What was given | Reported result | Limits |
|---|---|---|---|---|---|
| US 8,524,674[2], Example 8 | Patent report; groups described as random; no blinding stated | 25 adults with old head injuries | Injection into muscle once daily, 10 days | "Good" result in 59.4% | Written by the patent owner; percentages do not divide evenly into 25 |
| Nazimko 2012[20] | Uncontrolled, per abstract | Not in abstract | Capsule by mouth, 100 µg twice daily, 2 weeks | Better biological-age and adaptation scores | Abstract only |
| Bashkireva 2012[21] | Survey of two worker groups | 300 surveyed; treated number not stated | Pinealon plus vezugen | Better psycho-emotional scores | Combination, so pinealon's effect cannot be separated; abstract only |
| Umnov 2013[22] | Review citing a study | 72 (claimed) | Pinealon by mouth plus standard therapy | Better memory and less headache | The original study could not be found |
| Meshchaninov 2015[5] | No control group described | "32 people" (the listed men and women add to 30) | Pinealon and vezugen | Authors report an "anabolic effect" | Abstract only; numbers do not add up |
| Myakotnykh 2016[23] | Comparison of 4 methods | 110 | Vezugen plus pinealon vs baths, oxygen, massage | Largest effect on biological age | Combination; abstract only |
Sites that list "pinealon benefits" for memory, sleep or ageing rely on these reports. They are too weak to show that pinealon does any of these things.
We report these links as facts from the patent and the papers. They do not prove the results are wrong; they mean the results have not been checked by anyone without a stake in them.
| Source | Route | Amount as written | How often | How long | Study type |
|---|---|---|---|---|---|
| Nazimko 2012[20] | Capsule by mouth | 100 µg per capsule | Twice daily | 2 weeks | Small human study (uncontrolled, abstract only) |
| US 8,524,674[2], Ex. 8, mild group | Injection into muscle | 1.0 µg | Once daily | 10 days | Patent human report |
| US 8,524,674[2], Ex. 8, intermediate group | Injection into muscle | 10.0 µg | Once daily | 10 days | Patent human report |
| US 8,524,674[2], Ex. 8, severe group | Injection into muscle | "5.0 mg" as printed; probably a typo for µg | Once daily | 10 days | Patent human report |
| US 8,524,674[2], claim 2 | Not stated | 0.01 to 100 µg/kg (a patent claim, not a tested group) | At least daily | Not stated | Patent claim |
| Arutjunyan 2012[15] | Injection into abdomen (rats) | 10 µg/kg | Daily | 5 days | Animal |
| US 8,524,674[2], Ex. 6 | Injection into abdomen (rats) | 1 µg per animal | Daily | 10 days | Animal (patent) |
| US 8,524,674[2], Ex. 3 | Rat brain tissue in a dish | 10 ng/mL | Not applicable | 3 days | Cell (patent) |
Amounts as written in the source. Not a protocol.
Oral. The only sourced human oral figure is 100 µg twice daily for 2 weeks, from one uncontrolled report. Injected. The only human injection figures come from the patent. Neither is a protocol to follow, and none of the other amounts circulating online for pinealon comes from a study.
Your answer is saved only in this browser so you are not asked again. See the privacy policy.
There is no approved pinealon product or label, so nothing is preset: type the mg on your own vial. Pinealon is written in micrograms (µg, the same as mcg) in its sources; switch the amount to mcg if that is how your label reads. Mixing steps: how to reconstitute peptides.
| Report | What was reported | Rate | Study type |
|---|---|---|---|
| US 8,524,674[2], Example 8 | "No negative effect" in any patient | Stated for 25 people; no event table | Patent human report |
| Meshchaninov 2015[5] | Pro-oxidant activity and fewer CD34+ blood stem cells, read by the authors as suppressed blood-cell production | Not given | Small human study (abstract only) |
| Myakotnykh 2016[23] | Peptides described as among the "most safe" of 4 methods | Not quantified | Small human study (abstract only) |
| US 8,524,674[2], Example 2 | No toxic effects in mice (single dose up to 5 mg/kg), rats (90 days) and guinea pigs (6 months) at up to 1 mg/kg daily | None reported | Animal (patent) |
No controlled study has measured side-effect rates for pinealon, so how often side effects occur in people is unknown.
| Item | Status | Source |
|---|---|---|
| FDA approval | None found. No approved product or label | No FDA record found |
| FDA 503A safety-risk page | Not listed, and not among the "nominated but withdrawn" peptides (which include epitalon, semax and selank) | FDA, page dated 2026-04-22[24] |
| HHS draft peptide policy (2026-10-30) | Not covered | Federal Register 91 FR 68526[25] |
| FDA warning letters | None naming pinealon found. A 2026-06-17 letter to an online seller named Prostamax, another peptide of the same "bioregulator" type | FDA warning letter[26] |
| ClinicalTrials.gov | 0 studies | ClinicalTrials.gov[7] |
| WADA | Not named; the S0 catch-all for substances without government approval for human use probably applies | WADA Prohibited List[27] |
| Russia | Registered as a dietary supplement (BAA), not a medicine | RLS[6] |
| US patent 8,524,674 | Listed as expired for unpaid fees from October 2025 | Google Patents[2] |
Checked 2026-11-17.
Athletes should check with their anti-doping body before using pinealon. Our reading of WADA S0 is not a ruling.
| Feature | Pinealon | Epitalon | Pineamin |
|---|---|---|---|
| What it is | Synthetic tripeptide Glu-Asp-Arg[8] | Tetrapeptide Ala-Glu-Asp-Gly[10] | Another product from the same group; its makeup is unverified |
| Pineal gland evidence | No effect in pineal cell culture[3] | Raised Ki-67 and CGRP in the same culture[3] | A 2017 paper title claims it raises melatonin in older people[28]; we could not read the paper |
| FDA 503A history | Not listed[24] | Nominated, then withdrawn[24] | Not found |
Pinealon vs Cortexin (rats). In head-to-head rat studies, Cortexin had the larger effect on free radicals and caspase-3[19], while pinealon did better on maze learning[18].
No study has tested semax, selank and pinealon together, and there are no data on whether they can be mixed in the same syringe. Semax and selank were nominated for FDA's 503A list and then withdrawn; pinealon is not on that FDA page[24]. For general mixing steps, see how to reconstitute peptides.
Direct answers to what people search for. Bracketed numbers point to the sources at the end; the sections above have the detail.
Mostly memory, brain health and ageing. The support is cell and animal work plus small Russian reports with no proper comparison group. That cannot show it works.
Yes. It is a short chain of three amino acids: glutamic acid, aspartic acid and arginine[8].
One small Russian report gave 100 µg capsules by mouth twice a day for 2 weeks, with no comparison group[20]. That is a published figure, not advice.
Reports used capsules by mouth or shots into muscle. There is no tested plan to follow. The section on how it has been taken lists the amounts as published.
No study shows that. In the only study of pineal gland cells, pinealon changed nothing that was measured[3].
No. It is not approved, is not on FDA’s 503A lists and has no registered US trial.
It is not named on the WADA list. But WADA’s S0 rule for substances without government approval probably covers it. Check with your anti-doping body.
They are different peptides: pinealon is Glu-Asp-Arg and epitalon is Ala-Glu-Asp-Gly. In pineal cells in a dish, epitalon changed the markers measured and pinealon did not[3].